INTRODUCTION: There has been considerable progress in identifying early cognitive and biomarker predictors of Alzheimer's disease (AD). Neuropsychiatric symptoms (NPS) are common in AD and appear to predict progression after the onset of mild cognitive impairment or dementia. OBJECTIVES: The objective of the study is to examine the relationship between NPS in clinically normal older adults and subsequent cognitive decline in a population-based sample. METHODS: The Cache County Study on Memory in Aging consists of a population-based sample of 5,092 older adults. We identified 470 clinically normal adults who were followed for an average period of 5.73 years. NPS were evaluated at the baseline clinical assessment using the Neuropsychiatric Inventory (NPI). NPI domain scores were quantified as the product of frequency X severity in individual NPI domains, and then summed for the NPI-Total. Neuropsychological measures were collected at baseline and at each subsequent follow-up wave. Linear mixed-effects models assessed the association of NPI-Total, NPI-Depression, and NPI-Anxiety scores (obtained at baseline) on longitudinal change in neuropsychological performance, controlling for age, sex, and education. RESULTS: Baseline NPI-Total score was associated with a more rapid rate of decline in word list memory, praxis recall, and animal fluency. Baseline NPI-Depression was not associated with later decline on any of the cognitive tests, while baseline NPI-Anxiety was associated with decline in Symbol Digit Modality. CONCLUSION: In conclusion, among clinically normal older adults derived from this population-based study, total burden of NPS was associated with longitudinal cognitive decline. These results add to the evidence that NPS are risk factors for or clinical indicators of preclinical dementia syndrome. Our study was an exploratory study and we did not control for multiple comparisons.
INTRODUCTION: There has been considerable progress in identifying early cognitive and biomarker predictors of Alzheimer's disease (AD). Neuropsychiatric symptoms (NPS) are common in AD and appear to predict progression after the onset of mild cognitive impairment or dementia. OBJECTIVES: The objective of the study is to examine the relationship between NPS in clinically normal older adults and subsequent cognitive decline in a population-based sample. METHODS: The Cache County Study on Memory in Aging consists of a population-based sample of 5,092 older adults. We identified 470 clinically normal adults who were followed for an average period of 5.73 years. NPS were evaluated at the baseline clinical assessment using the Neuropsychiatric Inventory (NPI). NPI domain scores were quantified as the product of frequency X severity in individual NPI domains, and then summed for the NPI-Total. Neuropsychological measures were collected at baseline and at each subsequent follow-up wave. Linear mixed-effects models assessed the association of NPI-Total, NPI-Depression, and NPI-Anxiety scores (obtained at baseline) on longitudinal change in neuropsychological performance, controlling for age, sex, and education. RESULTS: Baseline NPI-Total score was associated with a more rapid rate of decline in word list memory, praxis recall, and animal fluency. Baseline NPI-Depression was not associated with later decline on any of the cognitive tests, while baseline NPI-Anxiety was associated with decline in Symbol Digit Modality. CONCLUSION: In conclusion, among clinically normal older adults derived from this population-based study, total burden of NPS was associated with longitudinal cognitive decline. These results add to the evidence that NPS are risk factors for or clinical indicators of preclinical dementia syndrome. Our study was an exploratory study and we did not control for multiple comparisons.
Authors: Paul B Rosenberg; Michelle M Mielke; Brian Appleby; Esther Oh; Jeannie-Marie Leoutsakos; Constantine G Lyketsos Journal: Int J Geriatr Psychiatry Date: 2010-09-15 Impact factor: 3.485
Authors: Matthew E Peters; Sarah Schwartz; Dingfen Han; Peter V Rabins; Martin Steinberg; Joann T Tschanz; Constantine G Lyketsos Journal: Am J Psychiatry Date: 2015-01-13 Impact factor: 18.112
Authors: David C Steffens; Kathleen A Welsh-Bohmer; James R Burke; Brenda L Plassman; John L Beyer; Kenneth R Gersing; Guy G Potter Journal: J Geriatr Psychiatry Neurol Date: 2004-12 Impact factor: 2.680
Authors: Kenneth M Langa; Brenda L Plassman; Robert B Wallace; A Regula Herzog; Steven G Heeringa; Mary Beth Ofstedal; James R Burke; Gwenith G Fisher; Nancy H Fultz; Michael D Hurd; Guy G Potter; Willard L Rodgers; David C Steffens; David R Weir; Robert J Willis Journal: Neuroepidemiology Date: 2005-08-15 Impact factor: 3.282
Authors: G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman Journal: Neurology Date: 1993-02 Impact factor: 9.910
Authors: Karra D Harrington; Emma Gould; Yen Ying Lim; David Ames; Robert H Pietrzak; Alan Rembach; Stephanie Rainey-Smith; Ralph N Martins; Olivier Salvado; Victor L Villemagne; Christopher C Rowe; Colin L Masters; Paul Maruff Journal: Int J Geriatr Psychiatry Date: 2016-04-25 Impact factor: 3.485
Authors: Yonas E Geda; Rosebud O Roberts; Michelle M Mielke; David S Knopman; Teresa J H Christianson; Vernon S Pankratz; Bradley F Boeve; Ondrej Sochor; Eric G Tangalos; Ronald C Petersen; Walter A Rocca Journal: Am J Psychiatry Date: 2014-05 Impact factor: 18.112
Authors: Kathryn V Papp; Rachel Buckley; Elizabeth Mormino; Paul Maruff; Victor L Villemagne; Colin L Masters; Keith A Johnson; Dorene M Rentz; Reisa A Sperling; Rebecca E Amariglio Journal: Alzheimers Dement Date: 2020-01-04 Impact factor: 21.566
Authors: Ronald C Petersen; Heather J Wiste; Stephen D Weigand; Julie A Fields; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Walter K Kremers; Val Lowe; Mary M Machulda; Michelle M Mielke; Nikki H Stricker; Terry M Therneau; Prashanthi Vemuri; Clifford R Jack Journal: Ann Neurol Date: 2021-04-06 Impact factor: 11.274
Authors: Michael J C Bray; Lisa N Richey; Barry R Bryant; Akshay Krieg; Sahar Jahed; William Tobolowsky; Christian LoBue; Matthew E Peters Journal: Alzheimers Dement Date: 2021-01-19 Impact factor: 21.566